{"entity":{"id":"idea-acc-gbci-country-dashboards","kind":"idea","name":"Public country dashboards for the three WHO breast cancer targets","aka":[],"tldr":"The WHO set three simple goals for breast cancer: most cancers found early, diagnosis within 60 days, and most patients finishing treatment. Every country should publish how it is doing on each, every year.","summary":"The WHO Global Breast Cancer Initiative pillars are: at least 60% of invasive cancers diagnosed at stage I-II, diagnosis within 60 days of presentation, and at least 80% of patients completing multimodal treatment. These are measurable with modest registry and hospital data. A public, comparable dashboard would focus ministries and donors on the delivery gaps rather than on new technology, and would show which policy changes move the numbers.","asOf":"2026-09-08","links":[{"label":"WHO Global Breast Cancer Initiative","url":"https://www.who.int/initiatives/global-breast-cancer-initiative"}],"tags":[],"related":["globocan"],"cancers":["breast-hr-positive","tnbc","breast-her2-positive"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-global-access","b-care-fragmentation","b-real-world-evidence"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Countries publishing annual GBCI indicators will improve at least two of the three indicators by ten percentage points within four years, faster than non-reporting comparators.","rationale":"Measurement with public accountability drove vaccine coverage and maternal mortality reporting; breast cancer has clear, accepted indicators but no reporting habit.","test":"Support ten countries to report baseline and annual indicators; compare trajectories with matched non-reporting countries using registry data.","maturity":"being-tested-at-scale","actor":"policy","cost":"medium","horizonYears":4},"route":"/ideas/idea-acc-gbci-country-dashboards/","neighbours":{"collection":[{"id":"globocan","kind":"collection","name":"GLOBOCAN / Global Cancer Observatory","route":"/collections/globocan/"}],"cancer":[{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"bottleneck":[{"id":"b-care-fragmentation","kind":"bottleneck","name":"Fragmented care and guideline gaps","route":"/bottlenecks/b-care-fragmentation/"},{"id":"b-global-access","kind":"bottleneck","name":"Most of the world has almost no cancer care","route":"/bottlenecks/b-global-access/"},{"id":"b-real-world-evidence","kind":"bottleneck","name":"Weak real-world evidence and registries","route":"/bottlenecks/b-real-world-evidence/"}]}}